View Post

U.S. CDC Confirms Sudan Ebolavirus Outbreak Risks

In COVID-19, Latest News by Precision Vaccinations

The U.S. Centers for Disease Control and Prevention (CDC) issued today Health Advisory CDCHAN-00477, focused on Uganda's current Sudan Ebolavirus disease (EVD) outbreak.
This is the fifth outbreak of EVD caused by the Sudan virus in Uganda since 2000. 
As of October 6, 2022, a total of 44 confirmed cases, ten confirmed deaths, and 20 probable deaths of EVD have been identified in Uganda since the outbreak began in September 2022.
The current Ebola outbreak has a 69% case fatality rate.

View Post

$4.8 Million Award Funds Betacoronavirus Vaccine Development

In COVID-19, Latest News by Precision Vaccinations

The Coalition for Epidemic Preparedness Innovations (CEPI) and Intravacc today announced the latest funding award to advance the development of vaccines that provide broad protection against SARS-CoV-2 (including its variants) and other Betacoronaviruses, which can be delivered intranasally.
Based in the Netherlands, the CEPI will provide seed funding of up to US$4.8 million to Intravacc, a world leader in translational research and development of preventive and therapeutic vaccines.

View Post

Most Extensive Avian Influenza Epidemic in Europe Ever

In Travel Vaccine News by Travel Vaccine

Influenza viruses circulating in animal species such as pigs or birds can sporadically infect humans, causing mild to very severe diseases, reported the European Centre for Disease Prevention and Control (ECDC).
These viruses have the potential to severely affect public health, such as during the epidemics of avian influenza H5N1 in Egypt or H7N9 in China, or the 2009 H1N1 influenza pandemic caused by a virus initially spreading from pigs to humans.

View Post

Herpes Gene Therapy Further Refined in Mice

In COVID-19, Latest News by Precision Vaccinations

Encouraging news from researchers at Fred Hutchinson Cancer Center in Washington recently showed that an experimental gene therapy for herpes simplex virus infections may suppress the amount of transmissible virus.
Drs. Keith Jerome and Martine Aubert, the virologists leading the research effort, reported the innovative treatment dramatically reduced or even eliminated viral shedding in treated mice compared to controls.